Gracure Pharmaceuticals Limited, a active public limited company, was established on 01 June 1992 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL1992PLC049002. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.25 Cr and a paid-up capital of ₹2.82 Cr.
It upholds a compliant status. Employing 529 professional, Its leadership includes Sudhir Bhargava (Whole-Time Director), Parag Bhargava (Whole-Time Director), Amreshwar Sahai Bhargava (Managing Director). Past directors included Chandreshwar Sahai Bhargava. It holds ₹20.88 Cr open charges and ₹18.45 Cr settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at 251-254 Iind Floor, Dlf Tower 15 Shivaji Marg, New Delhi, Delhi, 110015.
U24232DL1992PLC049002
049002
01 June 1992
₹5.25 Cr
₹2.82 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Gracure Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudhir Bhargava | Whole-Time Director | 27 Nov 2001 | Current |
| Parag Bhargava | Whole-Time Director | 10 Aug 2002 | Current |
| Amreshwar Sahai Bhargava | Managing Director | 25 Nov 1992 | Current |
| Harshad Vaid | Director | 05 May 1995 | Current |
| Pradeep Kumar Rastogi | Whole-Time Director | 13 Mar 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gracure Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.15% increase. The company also saw a substantial fall in profitability, with a 13.26% decrease in profit. The company's net worth Soared by an impressive increase of 15.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Gracure Pharmaceuticals had a promoter holding of 77.81% and a public holding of 22.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹208,820,150.00
₹184,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2025 | Axis Bank Limited | ₹10.00 Cr | Open |
| 25 Oct 2024 | Others | ₹1.40 Cr | Open |
| 07 Oct 2022 | Axis Bank Limited | ₹9.50 M | Open |
| 13 Sep 2021 | Hdfc Bank Limited | ₹1.12 M | Open |
| 10 Jun 2021 | Hdfc Bank Limited | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Gracure Pharmaceuticals has a workforce of 529 employees as of Aug 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gracure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gracure Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Axis Bank Limited amounted to Rs. 10.00 Cr with Charge ID 101155676 was registered on 27 Jun 2025. was documented.
The activity A charge with Others amounted to Rs. 1.40 Cr with Charge ID 101022120 was registered on 25 Oct 2024. was completed.
Progress on Gracure Pharmaceuticals Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
Gracure Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 0.95 Cr with Charge ID 100622109 was registered on 07 Oct 2022. was documented.
Progress on A charge with Others of Rs. 7.50 Cr registered on 26 Aug 2003 with Charge ID 90062917 was modified on 14 Sep 2021. was documented.
The CIN of Gracure Pharmaceuticals Limited is U24232DL1992PLC049002.
Gracure Pharmaceuticals Limited is headquartered at 251-254 Iind Floor, Dlf Tower 15 Shivaji Marg, New Delhi, Delhi, 110015.
Gracure Pharmaceuticals Limited was incorporated on 01 June 1992.
The current directors of Gracure Pharmaceuticals Limited are
The primary industry of Gracure Pharmaceuticals Limited is Manufacturing.
Gracure Pharmaceuticals Limited is unlisted.
The authorized capital of Gracure Pharmaceuticals Limited is ₹5.25 Cr, and the paid-up capital is ₹2.82 Cr.
The compliance status of Gracure Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX